Cuong, D. M., Jeon, J., Abubaker, Morgan. M. A., Kim, C., Kim, J. K., Lee, S. Y. and Park, S. U. (2017). Accumulation of charantin and expression of triterpenoid biosynthesis genes in bitter melon (Momordica charantia). J. Agric. Food Chem. 65: 720-24. doi:10.1021/acs.jafc.7b01948.
De Melo, C. G., Luiz Henrique Da Silva Pereira., Lucas Amadeu Gonzaga Da Costa., Aline Silva Ferreira, Lorena Vasconcelos De Araújo., Victor De Albuquerque Wanderley Sales., Stéfani Ferreira de Oliveira., Larissa Araújo Rolim., Tiago Feitosa Ribeiro. and Pedro José Rolim Neto. (2022). Experimental methodologies for the obtainment of Momordica charantia L. extracts with anthelminth activity: A Review. Pharmacog. Reviews 16: 82-89. doi:10.5530/phrev.2022.16.12.
Gayathry, K. S. and John, J. A. (2022). A comprehensive review on bitter gourd (Momordica charantia L.) as a gold mine of functional bioactive components for therapeutic foods. Food Prod. Process. Nutr. 4: doi:10.1186/s43014-022-00089-x.
Hamid, M. H. M. and Elsaman, T. (2017). A stability-indicating RP-HPLC-UV method for determination and chemical hydrolysis study of a Novel Naproxen Prodrug. J. Chem. 2017: doi:10.1155/2017/5285671.
Jia, S., Shen, M., Zhang, F. and Xie, J. (2017). Recent advances in Momordica charantia: Functional components and biological activities. Int. J. Mol. Sci. 18: 1-25. doi:10. 3390/ijms18122555.
Jiratchariyakul, W. and Mahady, G. B. (2013). Overview of botanical status in EU, USA, and Thailand. eCAM 2013: 1-13. doi:10. 1155/2013/480128.
Joseph, B. and Jini, D. (2013). Antidiabetic effects of Momordica charantia (bitter melon) and its medicinal potency. Asian Pac. J. Trop. Disease 3: 93-102. doi:10.1016/S2222-1808(13)60052-3.
Jyothi, M., Varaprasad, A., Vandana, B., Nikitha, G., Sandhya, S. and Sukanya, U. (2021). RP-HPLC method designed for determining charantin in its capsule dosage form. Future J. Pharm. Health. Sci. 1: 118-22. doi:10.26452/fjphs.v1i3.219.
Laczkó-Zöld, E., Bacsadi, B., Horváth, A. and Csupor, D. (2021). Development and validation of a RP-HPLC-DAD method for quantification of charantin in Momordica charantia products. J. Food Compos. Anal. 104: doi:10.1016/j.jfca.2021.104161.
Lolitkar, M. M. and Rao, M. R. R. (1966). Pharmacology of a hypoglycaemic principle isolated from the fruits of Momordica charantia Linn. Indian J. Pharm. 28: 129-33.
Marcus, Y. (2018). Extraction by subcritical and supercritical water, methanol, ethanol and their mixtures. Separations 5: doi:10.3390/separations5010004.
Nuchtavorn, Nantana, Jiraporn Leanpolchareanchai, Satsawat Visansirikul and Somnuk Bunsupa (2023). Optimization of magnetic and paper-based molecularly imprinted polymers for selective extraction of charantin in Momordica charantia" Int. J. Mol. Sci. 24: doi:10.3390/ijms24097870.
Oyelere, S. F., Ajayi, O. H., Ayoade, T. E., Pereira, G. B. S., Owoyemi, B. C. D., Ilesanmi, A. O. and Akinyemi, O. A. (2022). A detailed review on the phytochemical profiles and antidiabetic mechanisms of Momordica charantia. Heliyon 8: doi:10.1016/j.heliyon.2022.e09253.
Richter, E., Geetha, T., Burnett, D., Broderick, T. L. and Babu, J. R. (2023). The effects of Momordica charantia on Type 2 Diabetes Mellitus and Alzheimer's disease. Int. J. Mol. Sci. 24: doi:10.3390/ijms24054643.
Shahzadi, N., Mujahid-ul-Islam, Sajid, D. F., Haseeb-Ur-Rehman, M. and Hussain, S. T. (2023). Exploring the therapeutic potential of Momordica charantia (bitter gourd) in the management of diabetes mellitus. J. Popul. Ther. Clin. Pharmacol. 30: 837-49. doi:10.53555/jptcp.v30i18.3187.
Singh, V. and Maiti, R. K. (2020). Active substances and bitter ingredients in medicinal plants: An overview. Farm. Manage. 5: 39-53.
Sundari, A. R. U., Neelamegam, P. and Subramanian, C. V. (2013). An experimental study and analysis on solar drying of bitter gourd using an evacuated tube air collector in Thanjavur, Tamil Nadu, India. doi:10.1155/2013/125628.
Tan, S. P., Parks, S. E., Stathopoulos, C. E. and Roach, P. D. (2014). Extraction of flavonoids from bitter melon. Food Nutr. Sci. 05: 458-65. doi:10.4236/fns.2014.55054.
Tiwari, I., Upadhyay, A., Ansari, F., Rana, G. K., Deshmukh, K. K., Patidar, S., Nayak, P. S. and Singh, A. (2021). Effect of drying methods on proximates, sensorial quality and shelf life of dehydrated bitter gourd. Biol. Forum 13: 51-58.
Valyaie, A., Azizi, M., Kashi, A., Sathasivam, R., Park, S. U., Sugiyama, A., Motobayashi, T. and Fujii, Y. (2021). Evaluation of growth, yield, and biochemical attributes of bitter gourd (Momordica charantia L.) cultivars under Karaj conditions in Iran. Plants (Basel). 10: doi:10.3390/plants10071370.
Zaini, A. S., Aiysah Aris., Nicky Rahmana Putra., Syafiza Abd Hashib., Mohd Johari Kamaruddin., Zuhaili Idham and Mohd Azizi Che Yunus (2018). Comparison of charantin extract from Momordica charantia using modified supercritical carbon dioxide and Soxhlet extraction method . Malaysian J. Fundamental Appl. Sci. 14: 462-66. doi:10.11113/mjfas.v14n4.1092.
De Melo, C. G., Luiz Henrique Da Silva Pereira., Lucas Amadeu Gonzaga Da Costa., Aline Silva Ferreira, Lorena Vasconcelos De Araújo., Victor De Albuquerque Wanderley Sales., Stéfani Ferreira de Oliveira., Larissa Araújo Rolim., Tiago Feitosa Ribeiro. and Pedro José Rolim Neto. (2022). Experimental methodologies for the obtainment of Momordica charantia L. extracts with anthelminth activity: A Review. Pharmacog. Reviews 16: 82-89. doi:10.5530/phrev.2022.16.12.
Gayathry, K. S. and John, J. A. (2022). A comprehensive review on bitter gourd (Momordica charantia L.) as a gold mine of functional bioactive components for therapeutic foods. Food Prod. Process. Nutr. 4: doi:10.1186/s43014-022-00089-x.
Hamid, M. H. M. and Elsaman, T. (2017). A stability-indicating RP-HPLC-UV method for determination and chemical hydrolysis study of a Novel Naproxen Prodrug. J. Chem. 2017: doi:10.1155/2017/5285671.
Jia, S., Shen, M., Zhang, F. and Xie, J. (2017). Recent advances in Momordica charantia: Functional components and biological activities. Int. J. Mol. Sci. 18: 1-25. doi:10. 3390/ijms18122555.
Jiratchariyakul, W. and Mahady, G. B. (2013). Overview of botanical status in EU, USA, and Thailand. eCAM 2013: 1-13. doi:10. 1155/2013/480128.
Joseph, B. and Jini, D. (2013). Antidiabetic effects of Momordica charantia (bitter melon) and its medicinal potency. Asian Pac. J. Trop. Disease 3: 93-102. doi:10.1016/S2222-1808(13)60052-3.
Jyothi, M., Varaprasad, A., Vandana, B., Nikitha, G., Sandhya, S. and Sukanya, U. (2021). RP-HPLC method designed for determining charantin in its capsule dosage form. Future J. Pharm. Health. Sci. 1: 118-22. doi:10.26452/fjphs.v1i3.219.
Laczkó-Zöld, E., Bacsadi, B., Horváth, A. and Csupor, D. (2021). Development and validation of a RP-HPLC-DAD method for quantification of charantin in Momordica charantia products. J. Food Compos. Anal. 104: doi:10.1016/j.jfca.2021.104161.
Lolitkar, M. M. and Rao, M. R. R. (1966). Pharmacology of a hypoglycaemic principle isolated from the fruits of Momordica charantia Linn. Indian J. Pharm. 28: 129-33.
Marcus, Y. (2018). Extraction by subcritical and supercritical water, methanol, ethanol and their mixtures. Separations 5: doi:10.3390/separations5010004.
Nuchtavorn, Nantana, Jiraporn Leanpolchareanchai, Satsawat Visansirikul and Somnuk Bunsupa (2023). Optimization of magnetic and paper-based molecularly imprinted polymers for selective extraction of charantin in Momordica charantia" Int. J. Mol. Sci. 24: doi:10.3390/ijms24097870.
Oyelere, S. F., Ajayi, O. H., Ayoade, T. E., Pereira, G. B. S., Owoyemi, B. C. D., Ilesanmi, A. O. and Akinyemi, O. A. (2022). A detailed review on the phytochemical profiles and antidiabetic mechanisms of Momordica charantia. Heliyon 8: doi:10.1016/j.heliyon.2022.e09253.
Richter, E., Geetha, T., Burnett, D., Broderick, T. L. and Babu, J. R. (2023). The effects of Momordica charantia on Type 2 Diabetes Mellitus and Alzheimer's disease. Int. J. Mol. Sci. 24: doi:10.3390/ijms24054643.
Shahzadi, N., Mujahid-ul-Islam, Sajid, D. F., Haseeb-Ur-Rehman, M. and Hussain, S. T. (2023). Exploring the therapeutic potential of Momordica charantia (bitter gourd) in the management of diabetes mellitus. J. Popul. Ther. Clin. Pharmacol. 30: 837-49. doi:10.53555/jptcp.v30i18.3187.
Singh, V. and Maiti, R. K. (2020). Active substances and bitter ingredients in medicinal plants: An overview. Farm. Manage. 5: 39-53.
Sundari, A. R. U., Neelamegam, P. and Subramanian, C. V. (2013). An experimental study and analysis on solar drying of bitter gourd using an evacuated tube air collector in Thanjavur, Tamil Nadu, India. doi:10.1155/2013/125628.
Tan, S. P., Parks, S. E., Stathopoulos, C. E. and Roach, P. D. (2014). Extraction of flavonoids from bitter melon. Food Nutr. Sci. 05: 458-65. doi:10.4236/fns.2014.55054.
Tiwari, I., Upadhyay, A., Ansari, F., Rana, G. K., Deshmukh, K. K., Patidar, S., Nayak, P. S. and Singh, A. (2021). Effect of drying methods on proximates, sensorial quality and shelf life of dehydrated bitter gourd. Biol. Forum 13: 51-58.
Valyaie, A., Azizi, M., Kashi, A., Sathasivam, R., Park, S. U., Sugiyama, A., Motobayashi, T. and Fujii, Y. (2021). Evaluation of growth, yield, and biochemical attributes of bitter gourd (Momordica charantia L.) cultivars under Karaj conditions in Iran. Plants (Basel). 10: doi:10.3390/plants10071370.
Zaini, A. S., Aiysah Aris., Nicky Rahmana Putra., Syafiza Abd Hashib., Mohd Johari Kamaruddin., Zuhaili Idham and Mohd Azizi Che Yunus (2018). Comparison of charantin extract from Momordica charantia using modified supercritical carbon dioxide and Soxhlet extraction method . Malaysian J. Fundamental Appl. Sci. 14: 462-66. doi:10.11113/mjfas.v14n4.1092.